FDA panel backs Truqap in prostate cancer by 7-1
AstraZeneca (LSE:AZN) Climbs 1.87% To 13,948p After the FDA's Oncologic Drugs Advisory Committee voted 7-1, with one abstention, that its AKT inhibitor Truqap (capivasertib), combined with abiraterone and androgen deprivation therapy, carries a favourable benefit-risk profile for patients with PTEN-deficient metastatic hormone-sensitive prostate cancer. The recommendation is grounded in Phase III CAPItello-281 data and marks a significant step toward a potential full US approval in a high-value oncology indication.
Pearson posts 4% underlying growth, keeps guidance intact
Pearson (LSE:PSON) Trades at 1,079.5p After reporting 4% underlying Group sales growth In the first quarter, with its Virtual Learning division surging 21% As demand for digital education products continues to accelerate. The company confirms it remains on track to deliver its full-year 2026 guidance of mid-single-digit sales growth and adjusted operating profit of £640m–£685m.
NatWest lifts income guidance to top of range
NatWest Group now expects 2026 income to land at the Top end Of its previously guided £17.2bn–£17.6bn Range, citing updated interest rate assumptions and a stronger-than-anticipated first quarter. The revision signals that the bank's margin environment and lending volumes have held up better than the midpoint of its own forecasts implied heading into the year.
Santander UK completes £2.86bn TSB acquisition
Santander UK has closed its £2.65bn Cash purchase of the entire issued share capital of TSB Banking Group, a deal that vaults it into position as the Third largest high-street bank In the United Kingdom. The combination adds TSB's branch network and retail deposit base to Santander UK's existing operations, reshaping the competitive landscape of UK retail banking at a stroke.
Lansdowne pivots to graphite with Macaubas deal and £1.9m raise
Lansdowne Oil & Gas Agrees a conditional acquisition of São Gabriel Mineração Ltda, securing control of the Macaubas graphite project In Brazil, and simultaneously raises £1.9m Via a placing to fund exploration work. The move marks a strategic pivot for the company, repositioning it within the battery-materials supply chain at a time when graphite project development is attracting renewed investor interest.
Total Graphite reworks Montepuez project economics
Total Graphite (AIM:TGR) Edges up 1.14% To 1.4666p As it announces it is engaging consultants to update the 2017 Definitive Feasibility Study And Value Engineering Study for its Montepuez graphite project in Mozambique. The review is designed to revalidate project economics, test a lower-capital-expenditure phased development pathway, and underpin offtake and financing conversations with potential partners.
Active Energy pivots to Middle East digital-asset infrastructure
Active Energy Group (AIM:AEG) Falls 8.33% To 0.11p After announcing plans to place approximately 1.58bn new shares At 0.0825p Each to raise gross proceeds of £1.3m. The funds will be directed toward working capital and the acquisition and development of digital asset infrastructure in the Middle East, a sharp strategic departure from the company's prior energy focus.
Union Jack Oil's Crossroads spud pushed back on rig maintenance
Union Jack Oil Advises that the planned spud of the Crossroads Well In southern Oklahoma has been delayed while the contracted rig undergoes maintenance, with a revised spud date expected to be communicated in Early May. The delay is operationally driven and the well programme itself remains unchanged.
Accesso names Lee Cowie as new CEO
Accesso Technology Group (AIM:ACSO) Dips 0.32% To 270.14p As it confirms Lee Cowie Takes the helm as Chief Executive Officer with effect from 1 May, replacing Steve Brown, who steps down as CEO and as a Director. Brown remains available to the board through a handover period, providing continuity as Cowie assumes leadership of the ticketing and guest experience technology group.
